Quantcast

Latest Steatohepatitis Stories

2013-04-28 23:00:55

Oregon State University researchers say omega-3 fatty acid DHA, such as found in Omega XL, has a powerful effect in preventing liver inflammation and fibrosis. Hollywood, FL (PRWEB) April 28, 2013 One of the first studies to directly compare the effects of omega-3 fatty acids DHA and EPA on liver disease was recently published online in the Journal of Nutrition. The study, supported by the USDA National Institute of Food and Agriculture, as well as the National Institutes of Health,...

2013-04-25 10:32:52

Scientists at the Arkansas Children's Nutrition Center, a U.S. Department of Agriculture Agricultural Research Service Human Nutrition Research Center at the University of Arkansas for Medical Sciences, led by Dr. Martin Ronis have determined that dietary substitution of saturated fats enriched in medium chain triglycerides (MCT) for polyunsaturated fat prevents the development of nonalcoholic fatty liver disease (NAFLD). NAFLD occurs in patients with obesity and type II diabetes and is being...

Vitamin E Could Be Used As A Potential Weapon Against Obesity
2013-04-24 05:47:50

redOrbit Staff & Wire Reports - Your Universe Online Vitamin E could be a new weapon in the fight against obesity-related liver disease known as nonalcoholic steatohepatitis (NASH), according to new research conducted by researchers from the Case Western Reserve University School of Medicine, the Cleveland Clinic Foundation and Cornell University. “The implications of our findings could have a direct impact on the lives of the approximately 63 million Americans who are at...

2013-04-11 10:44:56

New research reveals that advanced fibrosis is a significant predictor of mortality in patients with nonalcoholic fatty liver disease (NAFLD), largely brought about by cardiovascular causes. NAFLD alone was not associated with increased mortality according to findings published in the April issue of Hepatology, a journal of the American Association for the Study of Liver Diseases. With super-sized portions, sugary soft drinks and physical inactivity, obesity is on the rise and showing no...

2012-07-04 22:46:49

Scientists at Texas Biomed have developed the laboratory opossum as a new animal model to study the most common liver disease in the nation — afflicting up to 15 million Americans — and for which there is no cure. The condition, nonalcoholic steatohepatitis (NASH), resembles alcoholic liver disease, but occurs in people who drink little or no alcohol. The major feature of NASH is accumulation of fat in the liver, along with inflammation and functional damage. Most people with...

2012-06-08 09:20:09

A new study from the Virginia Commonwealth University School of Medicine has identified molecular changes responsible for abnormal cholesterol production and metabolism in the livers of patients with a common liver condition, and these changes may explain the severity of a patient's liver disease and risks to their heart health. It is estimated that a third of Americans have a fatty liver. Nonalcoholic fatty liver disease is a very common liver condition. Nonalcoholic steatohepatitis, or...

2012-05-15 19:59:03

NAFLD (non-alcoholic fatty liver disease) is the most common type of liver disease in the developed world, affecting up to one-third of the US population. NAFLD is often associated with obesity and other parameters of the so-called "metabolic syndrome," which is a major risk factor for the development of cardiovascular disease. In a well-done study among subjects with NAFLD, the investigators have demonstrated that modest alcohol consumption (an average of up to 20 grams of alcohol per day...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related